Based upon its predictive ability in ER+ LNN patients we next investigated F/B in breast cancer patients treated with tamoxifen in a recurrent setting, and found that F/B is also associated with shorter PFS.
The SOLO 2 trial (ClinicalTrials.gov identifier: NCT01874353) uses the same design (germline BRCA mutations carriers, olaparib maintenance versus placebo after platinum-based chemotherapy), but in a recurrent setting (only platinum-sensitive relapse).
This combination was explored in the MITO-2 trial [39], a large randomized phase III Italian trial aiming to demonstrate the efficacy of carboplatin-LPD as an initial chemotherapy in light of the promising results observed in a recurrent setting [40].
And, though very engagingly performed by Walliams, Catherine Tate, Philip Glenister and others, Big School also demonstrates that educational dramas and comedy raise a recurrent set of decisions, to which there is a very limited number of solutions.
Our study provides novel insight into the early clinical manifestations of this form of 3-M syndrome, and demonstrates the utility of whole exome sequencing as a tool for prenatal diagnosis in particular when there is a family history suggestive of a recurrent set of clinical symptoms.
A third recurrent set of messages within the theme of engagement highlights the importance specifically of promoting community and parent participation (Bhutan, Japan, India, NZ, Sri Lanka, Thailand, Vanuatu), either through awareness raising or promoting active participation in provision of ECCE supports.
When the ELISA negative clones contain a large recurrent set, these clones might either be well-growing but have low-affinity/are non-specific (not interesting) or high affinity clones that somehow fail to produce enough VHH in order to obtain a positive ELISA signal (interesting).
Choline positron emitting tomography (PET) with computed tomography (CT) might be a good candidate for the identification of low volume metastases with a pooled sensitivity and specificity exceeding 85% on a per-patient basis in the recurrent setting [ 6, 7].
However, in the recurrent setting, radiosurgery is an FDA-approved treatment modality, but progression at the margin of the target is a ubiquitous pattern of failure.
Meanwhile, as BRCA2-mutant cells are more sensitive to platinum-based schedules, and BRCA2 mutations were associated with longer platinum-free duration than BRCA1 mutations and wild-type BRCA in ovarian cancer patients [15], this knowledge could influence chemotherapeutic choices in the recurrent setting as well with a new generation of drugs.
Our assay will be tested in a recurrent disease setting to more definitively evaluate predictive capacity prospectively.
